AUG 30, 2016 08:00 AM PDT

Human umbilical cord mesenchymal cells and the treatment of bronchopulmonary dysplasia

Speakers
  • Chief Executive Officer, Meridigen Biotech Co., Ltd., Taiwan
    Biography
      Dr. Willie Lin received his Bachelor of science in Animal Sciences from Tunghai University in Taiwan followed by a doctorate in Biochemistry from Kansas State University in the USA. He is currently serving as the Chief Executive Officer of Meridigen Biotech based in Taiwan. Dr. Lin's professional experience has included: Adjunct Associate Professor of the Master Program in Technology Management at Fu Jen Catholic University; Chairman and President of Microbio Co., Ltd and Fountain Biopharma, Inc; President and Chief Operating Officer at UniMed Venture Management, Inc; Associate Vice President of the Strategy and Planning Department at China Chemical and Pharmaceutical Co.; and Associate Vice President in the Overseas Business Department for the China Development Industrial Bank.

    Abstract:
    The human umbilical cord is a promising abundant source of mesenchymal stem cells (MSCs). Compare to other MSCs, the advantages of human umbilical cord MSCs (hUC-MSCs) are easily accessible and they have a short amplification time, high proliferation rate, lower immunogenicity, and abundance. Many studies have shown that hUC-MSCs have the ability to differentiate into three germ layers, to accumulate in damaged tissue or inflamed regions, to promote tissue repair, and to modulate immune response. Thus, they are attractive human cell–based therapies for the treatment of bronchopulmonary dysplasia, chronic obstructive pulmonary disease, ischemic stroke, neuron degenerative diseases, autoimmune diseases, etc.
     

    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    JUN 18, 2019 04:00 PM CEST
    C.E. CREDITS
    JUN 18, 2019 04:00 PM CEST
    DATE: June 18, 2019TIME: 7:00am PDT, 10:00 EDT, 4:00pm CET PSCs represent an important tool in a wide range of applications, including basic research, disease modeling, drug...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    Loading Comments...
    Show Resources